Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization

NCT04725201 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT04725201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04725201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Phase 4
Overall status
Recruiting
Start date
May 24, 2021
Completion date
May 1, 2027
Enrollment
188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amputation; traumatic, hand